Understand the source comparison
Best Wolverine Stack Dosage Tissue Repair 2026: Protocol Comparison
Acute Injury (first 72 hours) 500mcg Twice daily 5mg 3× weekly 4–6 weeks Maximum angiogenic response during inflammatory phase. Highest VEGF expression in vascular density studies Chronic Injury / Post-Surgical 250–350mcg 2–3mg 2× weekly 6–8 weeks Lower doses
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Acute Injury (first 72 hours)
- 500mcg
- Twice daily
- 5mg
- 3× weekly
- 4–6 weeks
- Maximum angiogenic response during inflammatory phase. Highest VEGF expression in vascular density studies
- Chronic Injury / Post-Surgical
- 250–350mcg
- 2–3mg
- 2× weekly
- 6–8 weeks
- Lower doses sufficient when injury timeline less critical. Maintains therapeutic levels without oversaturation
- Maintenance / Preventive
- 250mcg
- Once daily
- 2mg
- Once weekly
- Ongoing
- Suboptimal for active repair. BPC-157 half-life requires twice-daily dosing for sustained angiogenesis
- High-Dose Experimental
- 750–1000mcg
- 7.5–10mg
- 4 weeks
- No proportional benefit above 500mcg BPC-157 or 5mg TB-500 in receptor binding studies. Cost increase without efficacy gain